数据链接：
官方服务：
资源简介：
Centroids for luminal and HER2-enriched subtypes.
应用场景：
创建时间：
2016-09-28
相关数据集
Pam50 of a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Our aims is correlate the data and classification of the subtype breast cancer obtained with the Pam50 assay with the data obtained from the analysis of the same patients RNAseq Total RNA was obtained
NIAID Data Ecosystem60
DataSheet_1_The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients.zip
PurposesMost molecular-based published studies on breast cancer do not adequately represent the unique and diverse genetic admixture of the Latin American population. Searching for similarities and di
NIAID Data Ecosystem20
Additional file 5: of Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes
Scaled ASSIGN pathway activity predictions, phenotype, and k-means cluster calls for TCGA and ICBP samples. (XLSX 152Â kb)
Figshare2017-04-27 更新20
Association between select breast cancer risk factors and hormone receptor status.
1Results were estimated from case-only logistic regressions with adjustment for age at diagnosis.
Figshare2015-12-02 更新60
Associations between FNA-HER2 of 136 metastatic ALNs and clinicopathologic features of their primary breast cancers.
IHC: immunohistochemistry. aCases with no available results for each characteristic were excluded from data analysis: two cases for primary cancer size, 22 cases for HER2 FISH, and 29 cases for AR and
NIAID Data Ecosystem20
